CB-AC-02

N/A

Report date: 2023/01/12 15:28:48

Base Information

Drug NameCB-AC-02
Drug Alias NameCB-AC-02
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCHA Bio & Diostech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCHA Biotech Co LtdCHA Bio & Diostech Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A